Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Healthy Extracts (HYEX) EBIT (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of EBIT data on record, last reported at -$460113.0 in Q3 2025.

  • For Q3 2025, EBIT fell 638.82% year-over-year to -$460113.0; the TTM value through Sep 2025 reached -$869128.0, down 179.84%, while the annual FY2024 figure was -$183149.0, 91.84% up from the prior year.
  • EBIT reached -$460113.0 in Q3 2025 per HYEX's latest filing, down from -$105607.0 in the prior quarter.
  • Across five years, EBIT topped out at $85392.0 in Q3 2024 and bottomed at -$1.3 million in Q2 2023.
  • Average EBIT over 5 years is -$310648.9, with a median of -$254710.0 recorded in 2021.
  • Peak YoY movement for EBIT: crashed 787.56% in 2023, then skyrocketed 132.74% in 2024.
  • A 5-year view of EBIT shows it stood at -$662057.0 in 2021, then soared by 70.2% to -$197326.0 in 2022, then plummeted by 63.18% to -$321989.0 in 2023, then soared by 39.58% to -$194560.0 in 2024, then tumbled by 136.49% to -$460113.0 in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$460113.0 in Q3 2025, -$105607.0 in Q2 2025, and -$108848.0 in Q1 2025.